Cancer Institute A national cancer institute
designated cancer center

The Skin Cancer Program Team

The Stanford Skin Cancer Program has a strong multidisciplinary focus involving dermatology, medical and surgical oncology, dermatopathology, nuclear medicine, and radiation oncology. Specialists from this consultative and therapy-directed practice have broad expertise in the prevention, early detection, and management of all phases of both melanoma and non-melanoma skin cancers. 


Sumaira Aasi, MD Sumaira Z. Aasi, M.D.
Clinical Associate Professor of Dermatology
Director, Mohs and Dermatologic Surgery

Sumaira Z. Aasi completed her education and medical training at Northwestern University and the University of Chicago.  She subsequently completed a fellowship in advanced dermatologic surgery, cutaneous oncology and Mohs Micrographic surgery at Yale University.  After completing the fellowship, Dr. Aasi joined the Department of Dermatology at Yale University and became Associate Chief of the Section of Dermatologic Surgery and Cutaneous Oncology.  Dr. Aasi has over twenty-five publications and seventy-five presentations focusing on skin cancer and reconstruction.  She has lectured at both national and international meetings, chaired national meetings and serves on the Board of Directors for the American College of Mohs Surgeons.   Dr. Aasi’s clinical and research interests include non-melanoma skin cancer, high-risk skin cancer, histology and reconstruction.

Jennifer Boldrick, MDJennifer Boldrick, MD
Adjunct Clinical Faculty, Cutaneous Oncology
Department of Dermatology

Dr. Boldrick received a Bachelor of Arts degree from Vassar College. She worked in the laboratory of Dr. Louis Staudt in the National Cancer Institute at the NIH for 3 years prior to entering medical training at Stanford University School of Medicine.

Dr. Boldrick completed her residency training in Dermatology at Stanford University Medical Center. Throughout her residency, Dr. Boldrick focused on care of melanoma patients, seeing patients regularly in the Melanoma clinic and completing several research projects with Dr. Susan Swetter. Dr. Boldrick has treated Stanford Melanoma patients as Adjunct Clinical Instructor at the Stanford Melanoma Clinic since 2007. Dr. Boldrick works at the Redwood City location of the Palo Alto Medical Foundation.

Anne Chang, MD Anne Chang, MD

Anne Chang MD, assistant professor of dermatology and director of dermatological clinical trials, is an adult dermatologist whose research centers on novel therapies for non-melanoma skin cancers. She is also interested in how to promote healthy aging of the skin. She is a graduate of Harvard Medical School.


Howard Chang, MD Howard Chang


Paul A. Khavari, MD, PhD Paul A. Khavari, MD, PhD

Dr. Paul Khavari earned his undergraduate degree at Stanford prior to completing his M.D. studies at Yale. Subsequent to internship and dermatology residency training at Yale, he undertook Ph.D. and post-doctoral fellowship training in gene regulation at Stanford. He joined the faculty of Stanford School of Medicine in 1993 where he is now the Carl J. Herzog Professor and Chairperson of the Department of Dermatology and also Chief of the Dermatology Service at the VA Palo Alto Health Care System.

Dr. Khavari currently co-directs the Stanford Program in Epithelial Biology and serves as a member of the Stanford Program in Cancer Biology and the Stanford Institute for Stem Cell Biology and Regenerative Medicine. Dr. Khavari’s research is focused on understanding the molecular basis for skin cancer formation as a basis for development of new therapies. The Khavari laboratory focuses on developing new animal-free models of skin cancer, including basal cell carcinoma, squamous cell carcinoma, and melanoma and on new genetic insights into their pathogenesis.


Bernice Kwong, MDJustin Ko, MD
Clinical Assistant Professor, Dermatology



Bernice Kwong, MD Bernice Kwong, MD
Clinical Assistant Professor of Dermatology

M. Peter Marinkovich, MD, PhD M. Peter Marinkovich, MD

Dr. Marinkovich completed medical school at St. Louis University and completed his research and residency training at Oregon Health Sciences University. He joined the Stanford Department of Dermatology in 1995 where he currently is an Associate Professor. He is also a faculty member of the Stanford Cancer Biology PhD program, and a member of the Stanford Cancer Center.

Dr. Marinkovich’s basic research studies, which are funded by the National Cancer Institute, focus on the role of tumor microenvironment in cutaneous oncology. He has identified several new targets for therapy and diagnosis of squamous cell carcinoma and is currently working on preclinical development studies with Bristol-Meyers-Squibb and Cephalon in preparation for clinical trials.

Anthony Oro, MD, PhD Anthony Oro, MD, PhD

David Peng, MD David Peng, MD

Susan Swetter, MD Susan Swetter, MD
Professor of Dermatology
Director, Stanford Pigmented Lesion and Melanoma Program

Dr. Susan Swetter received her undergraduate degree from the University of Virginia and her medical degree from the University of Pennsylvania School of Medicine. She completed her dermatology training at Stanford and served as chief resident before joining the Stanford Dermatology faculty in 1994.

Dr. Swetter has directed the Pigmented Lesion and Melanoma Clinics at Stanford and the VA since 1995 and serves as Director of the Pigmented Lesion and Melanoma Program at the Stanford Cancer Institute.  Dr. Swetter is the national dermatologist liaison to the Eastern Cooperative Oncology Group (ECOG) Melanoma Committee, and co-chairs the interdisciplinary Melanoma Working Prevention Group, an Intergroup collaboration dedicated to melanoma control, primary and secondary prevention, and the emerging field of chemoprevention. She serves as the Stanford Principal Investigator for the NCI/University of Arizona Early Phase Cancer Chemoprevention Consortium and on both the National Comprehensive Cancer Network Melanoma Panel and American Academy of Dermatology Melanoma Practice Guidelines task force. Her research interests include prevention and early detection strategies for individuals at increased risk of melanoma, including skin screening, dermoscopy, and targeting high-risk groups for improved melanoma awareness. Dr. Swetter received the 2012 Humanitarian Award from the Melanoma Research Foundation.

Jean Tang, MD, PhD Jean Tang, MD, PhD

Medical Oncologists

Daniel Chen, MD, PhD Daniel Chen, MD, PhD
Adjunct Clinical Faculty, Medical Oncology

Dr. Chen received his Bachelor of Science degree in Biology from the Massachusetts Institute of Technology prior to completing a MD/PhD dual degree training at the University of Southern California. During his PhD training, Dr. Chen studied mechanisms of Coronavirus infection with Michael Lai, and gene therapy-based treatment of osteosarcoma with W. French Anderson.

Dr. Chen trained in Internal Medicine and Medical Oncology residency and fellowship at Stanford University Medical Center. Dr. Chen has treated Stanford Melanoma patients as Adjunct Clinical Instructor at the Stanford Melanoma Clinic since 2003. Dr. Chen leads efforts to develop new cancer immunotherapies and anti-angiogenic therapies for metastatic melanoma at Genentech as Associate Group Director in Exploratory Clinical Development. He also continues to actively publish scientific work related to melanoma and novel cancer therapy.

He remains active in the Stanford Pigmented Lesion and Melanoma Program, and continues to treat stage III and IV melanoma patients at Stanford. He is a vital resource for future melanoma research and trials.  His research interests include developing novel immune-based therapies for the treatment of melanoma, tumor angiogenesis, and new technology to monitor anti-melanoma immune responses.

Sunil Reddy, MD Sunil Reddy, MD
Staff physician, Medical Oncology
Co-Director, Stanford Multidisciplinary Melanoma Clinic

Dr. Reddy completed medical school at the University of California, Irvine and his internal medicine residency at the University of Michigan Medical Center. His fellowship in Oncology was completed at Stanford University Medical Center.  Following this he spent several years in the laboratory of Ronald Levy studying vaccine therapy for lymphomas. He sees stage III and IV melanoma patients on a regular basis (as well as those with advanced Merkel cell carcinoma) and leads the melanoma clinical trials available at Stanford. Dr. Reddy’s research interests include immunotherapy and targeted therapy of metastatic melanoma. He also directs Stanford's high dose Interleukin-2 therapy for patients with metastatic melanoma.

Radiation Oncologists

Sarah Donaldson, MD Sarah Donaldson, MD

Dr. Sarah S. Donaldson is the Catharine and Howard Avery Professor at Stanford University School of Medicine and Associate Program Director in the Department of Radiation Oncology at Stanford.  She also serves as the Chief of the Radiation Oncology service at the Lucile Packard Children’s Hospital at Stanford.  She is an established clinical investigator and educator with special interests in malignancies of the skin, eye/orbit, sarcoma, breast, lymphoma, and pediatric radiation therapy. She has a long time interest in the late effects of cancer and its treatment.  Dr. Donaldson received her undergraduate and nursing degrees from the University of Oregon and her MD from Harvard Medical School.  She joined the Department of Radiation Oncology for residency training at Stanford in 1969, was appointed to the faculty in 1973, and has served Stanford continuously since her initial appointment. 

A member of many professional organizations, Dr. Donaldson has held numerous national leadership roles.  She is a former president of both the American Board of Radiology and the American Society of Therapeutic Radiology and Oncology.  She also has served the Board of Directors of the American Society of Clinical Oncology and their Foundation, as well as the Board of Directors and Board of Trustees of the Radiological Society of North America, and their Foundation.

Dr. Donaldson has received numerous honors and awards including the Marie Curie Award of the American Association for Women Radiologists, the Janeway Medal of the American Radium Society, and the Henry S Kaplan Memorial Prize for teaching at Stanford.  She has received gold medals from the del Regato Foundation, the American College of Radiology, and the American Society for Therapeutic Radiology and Oncology.  She is a member of The National Academies Institute of Medicine.

Wendy Hara, MD Wendy Hara, MD

Steven Hancock, MD Steven Hancock, MD

Susan Knox, MD Susan Knox, MD

Dr. Susan Knox earned her undergraduate degree at the University of California Berkeley, her Ph.D. at the University of California Davis and M.D. at Stanford University. She completed residency and fellowship training at Stanford and joined the faculty in the Department of Radiation Oncology at Stanford in 1990.

Dr. Knox's laboratory and clinical research is focused on the use of local tumor radiation therapy in combination with targeted immunotherapies as in situ tumor vaccines, and the study of novel radiosensitizers, radioprotectors and biological response modifiers for use with radiation. Her work is translational with several clinical trials resulting from discoveries in her laboratory. She is also the Faculty Director of the Protocol Review and Monitoring System for the Stanford Cancer Institute and an Academic Advising Dean at the School of Medicine.

Surgical Oncologists

Ralph Greco, MD Ralph Greco, MD

John Sunwoo, MD John Sunwoo, MD


Jinah Kim, MD, PhDJinah Kim, MD, PhD
Director of Dermatopathology

Dr. Kim received her M.D., Ph.D. from Mount Sinai School of Medicine of New York University and trained in Anatomic Pathology at Yale University.  After completing a fellowship in dermatopathology at Yale Dermatology, Dr. Kim joined the faculty at Stanford University.
She currently is Assistant Professor of Pathology and Dermatology at Stanford University and Director of Dermatopathology Service and Fellowship.  She is board certified in both Anatomic Pathology and Dermatopathology.  She has received awards at the American Society of Dermatopathology for her work in melanocytic neoplasia and has served as consultation faculty at the American Society of Dermatopathology.  In addition, Dr. Kim serves on the editorial board of the Journal of Cutaneous Pathology and Clinical and Experimental Dermatology.

Uma Sundram, MD, PhD Uma Sundram, MD, PhD

Stanford Medicine Resources:

Footer Links: